Medarex/Centocor Extend Long-Term Antibody Development Relationship

J&J subsidiary has generated antibodies now in the clinic using Medarex’s UltiMAb technology, Medarex tells “The Pink Sheet” DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet